Rafael Nadal lost 6-4, 6-4 to Botic van de Zandschulp in the Davis Cup on Tuesday in what may have been the last match of the Spaniard's career.

J.P. Morgan analysts updated their “Analyst Focus List,” adding Tapestry (TPR), Alarm.com (ALRM), Regency Centers (REG), and Travere (TVTX). This is a list of stocks chosen by individual analysts ...

This award recognizes Padia’s creative vision to develop the HealthEquity Immersion Experience — a project that showcases HealthEquity’s deep understanding of the client and member benefits journey ...

HQY is a Zacks Rank #2 (Buy) stock, with a Growth Style Score of A and VGM Score of B. Earnings are expected to grow 37.3% ...

HealthEquity (HQY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate ...

Oct. 31, 2024 — A research team has found that giving iron supplements to children living with human immunodeficiency virus (HIV) in sub-Saharan Africa could be an ... Kidney Transplantation ...

This is a news collection page for Canberra. Check this page for latest news headlines covering major stories, events from Canberra and surrounding ACT. Get breaking news faster than any other ...

Fintel reports that on November 15, 2024, Goldman Sachs initiated coverage of HealthEquity (NasdaqGS:HQY) with a Neutral ...

Goldman Sachs initiates buy rating on Teladoc Health with $14 price target, while assigning neutral ratings on Doximity and HealthEquity. Read more here.

Barclays analyst Stephanie Davis maintained a Buy rating on Healthequity (HQY – Research Report) today and set a price target of $104.00. The company’s shares closed yesterday at $100.20. Davis covers ...

HealthEquity named Scott Cutler as its president and top executive, effective Jan. 6, succeeding Jon Kessler, who will retire after 15 years at the helm.